Tumor necrosis factor and wound healing

Area of Science:

• Wound healing research
• Immunology
• Biomedical engineering

Background:

• Tumor necrosis factor alpha (TNF) is a cytokine with complex roles in inflammation and tissue repair.
• Understanding TNF's localized effects on wound healing is crucial for therapeutic development.
• Adriamycin-induced impairment offers a model to study wound healing under compromised conditions.

Purpose of the Study:

• To investigate the impact of local and systemic Tumor Necrosis Factor alpha (TNF) administration on wound healing.
• To assess the effect of TNF delivery in different carriers (saline vs. collagen) on wound disruption strength (WDS) and histology.
• To evaluate the safety and efficacy of local TNF in normal and Adriamycin-impaired mice.

Main Methods:

• Wounds were created in normal and Adriamycin-impaired mice.
• Tumor Necrosis Factor alpha (TNF) was applied locally (5-500 ng) in saline (PBS) or collagen, or administered systemically (25-75 µg/kg IP).
• Wound disruption strength (WDS) and histology were assessed at various time points, including 6 months post-application.

Main Results:

• Local TNF in saline did not significantly alter WDS.
• Local TNF in collagen significantly increased WDS in Adriamycin-impaired mice (33-65%) and normal mice (23-49%).
• Adriamycin-impaired mice showed improved wound histology with local TNF in collagen; systemic TNF had no significant effect on WDS.

Conclusions:

• Local delivery of TNF within a collagen matrix enhances wound healing by increasing wound disruption strength.
• Collagen appears to be a suitable carrier for local TNF application, improving healing in both normal and compromised states.
• Local TNF application in collagen did not result in long-term histologic pathology, suggesting a favorable safety profile.